Sign in
Companies / BDX vs SOLV

BDX vs SOLV: Becton Dickinson and Solventum

Medical Devices
Compare more companies

Becton Dickinson (BDX) reported $21.8B in revenue against a 7.7% net margin, while Solventum (SOLV) reported $8.3B at a 18.7% net margin, most recently.

MetricBDXSOLV
Revenue$21.8B$8.3B
Net Income$1.7B$1.6B
Gross Margin45.4%53.5%
Operating Margin11.8%26.2%
EPS (Diluted)$5.82$8.88
Free Cash Flow$2.7B$-10.0M
Total Debt$19.2B$5.0B
P/E Ratio32.2×8.9×
P/B Ration/m2.7×
Stock Price$211.95$87.11
Fiscal yearFY2022FY2023FY2024FY2025
BDX Revenue$18.9B$19.4B$20.2B$21.8B
SOLV Revenue$8.1B$8.2B$8.3B$8.3B

More on BDX

More on SOLV

Other comparisons